788 related articles for article (PubMed ID: 19606066)
21. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain.
Kocisko DA; Lansbury PT; Caughey B
Biochemistry; 1996 Oct; 35(41):13434-42. PubMed ID: 8873612
[TBL] [Abstract][Full Text] [Related]
22. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
Cronier S; Laude H; Peyrin JM
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
[TBL] [Abstract][Full Text] [Related]
23. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
24. The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain.
Arnold JE; Tipler C; Laszlo L; Hope J; Landon M; Mayer RJ
J Pathol; 1995 Aug; 176(4):403-11. PubMed ID: 7562256
[TBL] [Abstract][Full Text] [Related]
25. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
26. Valproic acid treatment results in increased accumulation of prion proteins.
Shaked GM; Engelstein R; Avraham I; Rosenmann H; Gabizon R
Ann Neurol; 2002 Oct; 52(4):416-20. PubMed ID: 12325069
[TBL] [Abstract][Full Text] [Related]
27. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
[TBL] [Abstract][Full Text] [Related]
28. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
Safar J; Roller PP; Gajdusek DC; Gibbs CJ
Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
30. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
31. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
32. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
33. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation.
Xi YG; Ingrosso L; Ladogana A; Masullo C; Pocchiari M
Nature; 1992 Apr; 356(6370):598-601. PubMed ID: 1348570
[TBL] [Abstract][Full Text] [Related]
34. [Establishment of a protein misfolding cyclic amplification for PrPSc].
Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
[TBL] [Abstract][Full Text] [Related]
35. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
[TBL] [Abstract][Full Text] [Related]
36. Assessing the role of oxidized methionine at position 213 in the formation of prions in hamsters.
Silva CJ; Onisko BC; Dynin I; Erickson ML; Vensel WH; Requena JR; Antaki EM; Carter JM
Biochemistry; 2010 Mar; 49(9):1854-61. PubMed ID: 20121218
[TBL] [Abstract][Full Text] [Related]
37. Involvement of glypican-1 autoprocessing in scrapie infection.
Löfgren K; Cheng F; Fransson LA; Bedecs K; Mani K
Eur J Neurosci; 2008 Sep; 28(5):964-72. PubMed ID: 18717736
[TBL] [Abstract][Full Text] [Related]
38. Novel mechanisms of degeneration of the central nervous system--prion structure and biology.
Prusiner SB; Stahl N; DeArmond SJ
Ciba Found Symp; 1988; 135():239-60. PubMed ID: 2900720
[TBL] [Abstract][Full Text] [Related]
39. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene.
Büeler H; Raeber A; Sailer A; Fischer M; Aguzzi A; Weissmann C
Mol Med; 1994 Nov; 1(1):19-30. PubMed ID: 8790598
[TBL] [Abstract][Full Text] [Related]
40. Cell-free formation of protease-resistant prion protein.
Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
